» Articles » PMID: 37426199

The Risk Model Construction of the Genes Regulated by H3K36me3 and H3K79me2 in Breast Cancer

Overview
Journal Biophys Rep
Specialty Biochemistry
Date 2023 Jul 10
PMID 37426199
Authors
Affiliations
Soon will be listed here.
Abstract

Abnormal histone modifications (HMs) can promote the occurrence of breast cancer. To elucidate the relationship between HMs and gene expression, we analyzed HM binding patterns and calculated their signal changes between breast tumor cells and normal cells. On this basis, the influences of HM signal changes on the expression changes of breast cancer-related genes were estimated by three different methods. The results showed that H3K79me2 and H3K36me3 may contribute more to gene expression changes. Subsequently, 2109 genes with differential H3K79me2 or H3K36me3 levels during cancerogenesis were identified by the Shannon entropy and submitted to perform functional enrichment analyses. Enrichment analyses displayed that these genes were involved in pathways in cancer, human papillomavirus infection, and viral carcinogenesis. Univariate Cox, LASSO, and multivariate Cox regression analyses were then adopted, and nine potential breast cancer-related driver genes were extracted from the genes with differential H3K79me2/H3K36me3 levels in the TCGA cohort. To facilitate the application, the expression levels of nine driver genes were transformed into a risk score model, and its robustness was tested via time-dependent receiver operating characteristic curves in the TCGA dataset and an independent GEO dataset. At last, the distribution levels of H3K79me2 and H3K36me3 in the nine driver genes were reanalyzed in the two cell lines and the regions with significant signal changes were located.

Citing Articles

Role of Oxidative Stress in the Occurrence, Development, and Treatment of Breast Cancer.

Dong R, Wang J, Guan R, Sun J, Jin P, Shen J Antioxidants (Basel). 2025; 14(1).

PMID: 39857438 PMC: 11760893. DOI: 10.3390/antiox14010104.


A prognostic model for acute myeloid leukemia based on ferroptosis-related lncRNA and immune infiltration analysis.

Liu S, Chen Y, Li Q, Fan Z, Li M, Du P Biophys Rep. 2025; 10(6):377-387.

PMID: 39758420 PMC: 11693502. DOI: 10.52601/bpr.2024.240029.


Effects of Differentially Methylated CpG Sites in Enhancer and Promoter Regions on the Chromatin Structures of Target LncRNAs in Breast Cancer.

Fan Z, Chen Y, Yan D, Li Q Int J Mol Sci. 2024; 25(20).

PMID: 39456830 PMC: 11507307. DOI: 10.3390/ijms252011048.


Coregulatory effects of multiple histone modifications in key ferroptosis-related genes for lung adenocarcinoma.

Qi Y, Bai H, Hu S, Li S, Li Q Epigenomics. 2024; .

PMID: 38511238 PMC: 11160448. DOI: 10.2217/epi-2023-0403.

References
1.
Nienhuis H, Gaykema S, Timmer-Bosscha H, Jalving M, Brouwers A, Lub-de Hooge M . Targeting breast cancer through its microenvironment: current status of preclinical and clinical research in finding relevant targets. Pharmacol Ther. 2014; 147:63-79. DOI: 10.1016/j.pharmthera.2014.11.004. View

2.
Rahman M, Brane A, Tollefsbol T . MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer. Cells. 2019; 8(10). PMC: 6829616. DOI: 10.3390/cells8101214. View

3.
Duan C, Wang H, Chen Y, Chu P, Xing T, Gao C . Whole exome sequencing reveals novel somatic alterations in neuroblastoma patients with chemotherapy. Cancer Cell Int. 2018; 18:21. PMC: 5816515. DOI: 10.1186/s12935-018-0521-3. View

4.
Morgan M, Shilatifard A . Reevaluating the roles of histone-modifying enzymes and their associated chromatin modifications in transcriptional regulation. Nat Genet. 2020; 52(12):1271-1281. DOI: 10.1038/s41588-020-00736-4. View

5.
Zhang L, Liu J, Liu L, Fan G, Li Y, Li Q . The impact of gene-body H3K36me3 patterns on gene expression level changes in chronic myelogenous leukemia. Gene. 2021; 802:145862. DOI: 10.1016/j.gene.2021.145862. View